StockWatch
·
Pharmaceuticals
Insider Trading28 Sept 2026, 05:30 pm

Phaarmasia Ltd Closes Trading Window for Q2 FY27 Results

AI Summary

Phaarmasia Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, and SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be shut from October 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026. This restriction applies to all designated persons, their immediate relatives, and connected persons, including directors and key managerial personnel, to prevent insider trading.

Key Highlights

  • Trading window closed for Q2 FY27 financial results.
  • Closure effective from October 01, 2026.
  • Applies to designated persons and connected individuals.
  • Aims to prevent insider trading as per SEBI regulations.